This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 May 8;9(7):373.

doi: 10.1038/nrcardio.2012.67.

Heart failure: Lixivaptan reduces volume overload in patients with heart failure

PMID: 22566061
DOI: 10.1038/nrcardio.2012.67

Comment

Heart failure: Lixivaptan reduces volume overload in patients with heart failure

Gregory B Lim. Nat Rev Cardiol. 2012.

. 2012 May 8;9(7):373.

doi: 10.1038/nrcardio.2012.67.

Author

PMID: 22566061
DOI: 10.1038/nrcardio.2012.67

No abstract available

PubMed Disclaimer

Comment on

The efficacy and safety of lixivaptan in outpatients with heart failure and volume overload: results of a multicentre, randomized, double-blind, placebo-controlled, parallel-group study.
Ghali JK, Orlandi C, Abraham WT; CK-LX2401 Study Investigators. Ghali JK, et al. Eur J Heart Fail. 2012 Jun;14(6):642-51. doi: 10.1093/eurjhf/hfs051. Epub 2012 Apr 17. Eur J Heart Fail. 2012. PMID: 22510424 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.